Drug intelligence / Profile preview

5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule belonging to the class of quinazoline derivatives and n-benzylpiperidines. It has been studied as an experimental drug candidate with potential biological activities including enzyme inhibition. Notably, it acts as a potent inhibitor of m7GpppX diphosphatase (also known as scavenger decapping enzyme DcpS), with nanomolar affinity. It also shows weak inhibitory activity against cytochrome P450 2D6 and dihydrofolate reductase in vitro. The compound has not been approved for any therapeutic use and is primarily used in research settings to study RNA metabolism and related cellular processes. No clinical trials or approved indications are reported for this molecule.

Other names
5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine5-{[1-(2-Fluorbenzyl)-4-piperidinyl]methoxy}-2,4-chinazolindiamin5-{[1-(2-Fluorobenzyl)-4-piperidinyl]methoxy}-2,4-quinazolinediamine5-{[1-(2-Fluorobenzyl)-4-pipéridinyl]méthoxy}-2,4-quinazolinediamine (French)5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline‑2,4‑diamine (IUPAC)
02

Targets

DcpS (m7GpppX diphosphatase)CYP2D6 (Cytochrome P450 2D6)DHFR (Dihydrofolate reductase)

Beyond the preview

Go deeper on 5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 5-{[1-(2-fluorobenzyl)piperidin-4-yl]methoxy}quinazoline-2,4-diamine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call